What news does UroToday cover?
UroToday® publishes online medical articles about urology diseases organized by conditions, treatments, and evidence-based guidelines: prostate cancer; metastatic castration resistant prostate cancer (mCRPC and CRPC); bladder cancer; non–muscle invasive bladder cancer; metastatic bladder cancer; upper urinary tract urothelial tumors; renal cancer; metastatic renal cell carcinoma; lower urinary tract symptoms (LUTS); BPH; urinary retention, bladder outlet obstruction; overactive bladder; urinary incontinence; nocturia (night time voiding); urologic catheters; catheter-associated urinary tract infections (CAUTI); urology training for clinical practice;, stone disease such as kidney stones and bladder stones; and minimally invasive procedures.
Who creates and reviews the articles on UroToday?
Teams of experienced medical professionals are the editors and writers who create UroToday articles, commentaries and Beyond the Abstract submissions. Clinical content is reviewed and approved by our editorial board under the direction of the Editor-in-Chief, Thomas E. Keane.
Do you sell my registration information to other companies?
Can I suggest a topic or story for UroToday to cover?
Yes. If there is a topic or issue that you wish to submit, please email us at . While we review all feedback, we may not be able to individually respond to all submissions.
What is an Expert Patient?
An Expert Patient is a motivated, well-informed patient or caregiver who is familiar with the basics on a particular medical condition. The Expert Patient is highly engaged in his or her healthcare decisions and seeks more detailed information about health conditions. The Expert Patient visits UroToday to access the same breaking medical news that their healthcare professionals read.